Three familial cases of fundic gland polyposis without polyposis coli

We report three cases of fundic gland polyposis in the stomach identified in three patients who were related. Grossly the numerous polyps covered an area limited to the body and fundus of the stomach, no polyps were found in the antrum, duodenum, colon, or rectum, and histologically, the gastric lesions consisted of numerous hamartomatous polyps, characterized by proliferation of the fundic and cystic glands. The gastric lesions were identified in families without polyposis coli. This type of fundic gland polyposis has never been documented before in the literature.     

原位检测新基因SNC66在胃癌组织与正常胃粘膜中的表达

目的: 观察新基因SNC66在胃癌组织中的表达水平,分析SNC66表达水平与胃癌发生的相关性。 方法:以β-actin为对照,对20例胃癌组织及其配对正常胃粘膜的石蜡切片,进行原位cRNA/mRNA分子杂交和原位RT-PCR扩增。 结果:两种检测方法表明,SNC66在正常胃粘膜组织中都呈强阳性表达。而在胃癌组织中,原位分子杂交检测表明,20例标本SNC66不表达和弱阳性表达各8例,强阳性表达4例。原位RT-PCR检测表明,当循环数为10时,此20例胃癌标本中不表达、弱阳性和呈强阳性表达数分别为6,9和5;而当循环数为25时,则4例不表达,16例呈强阳性表达。 结论:SNC66基因在胃癌组织中存在明显的表达降低和表达缺陷。SNC66可以作为一个胃癌负相关基因加以进一步研究。     

Non-redundancy of cytidine deaminases in class switch recombination

Class switch recombination (CSR), somatic hypermutation, and gene conversion are immunoglobulin diversification mechanisms that are strictly dependent on the activity of the activation-induced cytidine deaminase (AID). The precise role and substrate(s) of AID in these processes remain to be well defined. The closest homologue of AID is APOBEC-1, a bona fide mRNA-editing enzyme, which shares with AID the ability to deaminate cytidines within single-stranded DNA in vitro and in prokaryotic cells. To determine whether APOBEC-1 can therefore substitute for AID in activated B cells, we expressed human AID, a catalytic mutant thereof, and rat APOBEC-1 in AID-deficient murine B cells. Whereas AID rescued CSR, neither the inactive mutant nor APOBEC-1 could complement AID deficiency. This indicates that cytidine deaminase activity is necessary but not sufficient to initiate CSR, and suggests that AID is specifically targeted to its cognate substrate, the immunoglobulin genes or a distinct mRNA, by an as-yet-unknown mechanism.     

消化道癌症患者血浆纤维连接蛋白的变化及其与微血管的关系

分析27例消化道癌症患者(其中胃癌18例,食道癌与结肠癌9例)和6例胃溃疡病人的血浆纤维连接蛋白(Fn)的变化。结果发现三者间无明显差异(P>0.05),但胃癌病人中有转移病灶者(n=7)及伴胃炎者(n=10)与相应对照组比,血浆Fn有非常明显降低(p<0.01)。胃癌组织中Fn免疫荧光主要集中在胃癌病人胃壁组织多形核白细胞浸润的炎症区及微血管周围,癌变区Fn免疫荧光很弱,甚至消失。对上述变化的意义进行了讨论。     

Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice

To compare the function of the tumor necrosis factor (TNF) and lymphotoxin (LT)α/β systems in the mature immune system, these two pathways were blocked with soluble receptor-immunoglobulin (R-Ig) fusion proteins in normal adult mice. Inhibition of LTα/β signaling using LTβR-Ig or a blocking monoclonal antibody against murine LTβ had profound effects. The spleen lacked discrete B cell follicles and the marginal zone was altered. Less marked changes were detected in lymph nodes. LTα/β inhibition also prevented germinal center formation in the spleen and impaired Ig production in response to sheep red blood cells (SRBC) immunization. These results show that the LTα/β system is required for the maintenance of splenic architecture and normal immune responses, and not simply for the development of peripheral immune organs during ontogeny. In contrast, inhibition of the TNF/LTα pathway with TNF-R55-Ig did not affect the splenic architecture or the anti-SRBC response. Splenic defects and impaired antibody responses are seen in TNF-deficient mice, suggesting that TNF is important during development. Therefore relative to TNF, the LT system has the dominant influence on splenic organization and anti-SRBC Ig formation in the adult mouse.     

组胺H_2受体阻断剂对大鼠失血性应激反应时胃功能和溃疡指数的影响

用反射光谱法,研究了组胺H_2受体阻断剂Famotidine对急性失血大鼠胃粘膜血液量及血氧饱和度的影响。同时观察了胃液量和酸排出量的变化,并计量了溃疡指数。Famotidine(3mg/kg及8mg/kg,iv)对失血前大鼠胃粘膜血液量和血氧饱和度均未见有影响;对失血后胃粘膜血液量和血氧饱和度的降低有明显保护作用,对胃液量和酸排出量均有显著抑制作用,溃疡指数减小。     

胃癌的细胞增殖、DNA增殖分数和倍性与患者生存的关系

目的：探讨胃癌细胞增殖、DNA增殖分数(S+G2/M期)和倍性与胃癌患者生存和生物学特性的关系。 方法： 应用流式细胞术，分别分析胃癌细胞群体的增殖、DNA增殖分数和倍性。 结果： 胃癌细胞群体的增殖和增殖分数之间无明显相关关系(P>0.05)；它们与胃癌患者的生存亦无明显相关关系(P>0.05)。胃癌细胞群体的增殖和DNA倍性与胃癌临床病理参数之间无明显相关关系(P>0.05)。胃癌患者DNA二倍体组和异倍体组Kaplan-Meier生存曲线经Log-rank检验有统计学差异（P<0.05）。 结论： 胃癌细胞的增殖和增殖分数与胃癌患者的生存无明显关系； DNA倍性分析对胃癌预后的判断具有重要参考价值。     

白藜芦醇诱导人胃癌原代细胞裸鼠移植瘤凋亡的研究

目的：探讨白藜芦醇诱导人胃癌原代细胞裸鼠移植瘤凋亡的机制。 方法： 建立人胃癌原代细胞裸鼠移植瘤模型，采用瘤旁注射的方法，用不同剂量的白藜芦醇进行治疗，并设对照，用透射电镜和TUNEL法检测肿瘤组织细胞凋亡情况，免疫组织化学法和RT-PCR法检测肿瘤组织的凋亡相关基因bcl-2和bax的表达情况。 结果： 白藜芦醇对胃癌原代细胞移植瘤有明显的抑制作用； 透射电镜和TUNEL法发现白藜芦醇导致移植瘤内大量细胞发生凋亡；免疫组织化学法发现白藜芦醇注射组的Bcl-2蛋白阳性细胞率（3.92％±0.85％、5.70％±0.84％和11.86％±0.97％）明显低于两个对照组（P<0.05），两个对照组（27.56％±1.40％和29.48％±0.51％）之间无显著差异；Bax蛋白阳性细胞率（52.30％±1.54％、45.72％±0.88％和40.02％±1.20％）明显高于两个对照组（P<0.05），两个对照组（20.88％±0.91％和19.34％±0.35％）之间无显著差异； RT-PCR法发现白藜芦醇注射组的bcl-2 mRNA条带强度随剂量的增大而递减，并明显低于两个对照组（P<0.05），两个对照组之间无显著差异（P>0.05）；bax mRNA条带强度递增，并明显高于两个对照组（P<0.05），两个对照组之间无显著差异（P>0.05）。 结论： 白藜芦醇对胃癌原代细胞移植瘤有明显的抑制作用，通过下调bcl-2 的表达和上调bax 的表达而诱导胃癌裸鼠移植瘤细胞发生凋亡，是其抗胃癌作用的机制之一。